Skip to main content

Withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes

ABCD is keen to ensure that all our members are aware of the withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes .
Apologies if you've had this update from multiple sources.
We are currently collating feedback on this decision from experts in this area, to share with ABCD members to ensure that people with Type 1 diabetes get the best care and can make informed decisions. 
 

JBDS needs your help

JBDS is updating the ‘Variable rate intravenous insulin infusion (VRIII) for medical inpatients with diabetes’ guideline and we need your help.

We need to collect evidence and are asking UK diabetes teams to let us know what they are currently doing by completing online forms.  This can be done either by downloading the form from https://forms.office.com/r/BTM64H2qMj or by scanning the attached QR code.

We are looking to get information on 5 people on a VRIII from each hospital

Sanofi Inspired Diabetes Symposium

 

Join us at the Sanofi Inspired Diabetes Update webinar. An opportunity for a multidisciplinary approach to inform and empower you with knowledge from a diverse range of subjects, impacting on different aspects of diabetes management with the key GIRFT recommendations in mind to improve care of our patients.

National speakers have been brought together for all lectures and informal Q & A. Please join us on the 21st October at 4.00-6.00 pm. CPD accreditation have been applied for this meeting.